RareResearch.AI
← Back to atlas

H401Y

Category 3/4 — Most DruggableUncertain significanceTransmembrane · predictedSource card
HistidineTyrosine at position 401 · Transmembrane helix 4 · WFS1 (Wolframin)

Interactive 3D Structure

Wild-type reference
Wild-type H401 — ionic bond to D367
Fullscreen ↗
DynaMut2 mutant · H401Y
Mutant Y401 — ionic bond to D367 lost (4 contacts lost)
Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

4 lost9 gained10 preserved
Interaction typeWild-type partnerMutant partnerStatus
Ionic bondD367Lost
Hydrogen bondG257Gained
Hydrogen bondI259Gained
Hydrogen bondF397F397Preserved
Hydrogen bondG398Lost
Hydrogen bondP404P404Preserved
Polar contactG257Gained
Polar contactI259I259Preserved
Polar contactD367Gained
Polar contactF397F397Preserved
Polar contactG398G398Preserved
Polar contactW399W399Preserved
Polar contactE403Gained
Polar contactP404P404Preserved
Aromatic / πF397F397Preserved
Van der WaalsD367Gained
Van der WaalsF397F397Preserved
Van der WaalsW399Gained
Van der WaalsE403Lost
Van der WaalsP404Lost
HydrophobicI259Gained
HydrophobicD367Gained
HydrophobicF397F397Preserved

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG
1.13kcal/mol
Stabilising — moderate
AlphaMissense
0.747
likely pathogenic
AlphaFold pLDDT
82
model confidence
Schema
Cat 3/4
Category 3/4 — Most Druggable

Clinical Evidence

ClinVar classificationUncertain significance
Review statuscriteria provided, single submitter
Associated conditions
Population frequency (gnomAD v4)Ultra-rare · AF 0.00082%
cDNA changec.1201C>T
ClinVar accessionVCV002134530
Last evaluated2023/08/30 00:00

Observed at very low frequency in gnomAD.

Full Variant Card

WFS1 Wolframin — H401Y Variant Card

Molecular Atlas Pilot · RareResearch.AI · Generated by wolfram-variant-card skill

Histidine → Tyrosine at position 401. Transmembrane helix 4. ClinVar Uncertain significance, AlphaMissense 0.747, DynaMut2 ΔΔG +1.13 kcal/mol (stabilising).


Identity

FieldValue
VariantH401Y (p.Histidine401Tyrosine)
DNA changec.1201C>T
Gene · ProteinWFS1 · Wolframin (890 aa)
UniProtO76024 · WFS1_HUMAN
ClinVar accessionVCV002134530
Amino acid changeHistidine (H) → Tyrosine (Y)

Structural Context

FieldValue
AlphaFold modelAF-O76024-F1, v6
pLDDT at residue 40181.94 — well-folded
DomainTransmembrane helix 4
Position contextInside Transmembrane helix 4 · position 401 is bilayer-embedded
IDR flagNo — pLDDT above 50 threshold

UniProt features at this position:

(none catalogued)

Position 401 sits in a transmembrane helix (Transmembrane helix 4). Wolframin has eleven such helices anchoring it in the ER membrane; substitutions inside the bilayer-embedded segments can disrupt helix packing, lipid contacts, and the overall ER topology of the protein. The wild-type residue is titratable basic (histidine — imidazole); the mutant is aromatic with hydroxyl (tyrosine — H-bond donor/acceptor). The chemistry shift implies altered local packing, hydrogen-bonding, and/or electrostatics at this site.


Computational Predictions

AlphaMissense

FieldValue
am_pathogenicity0.7471
am_classlikely pathogenic
InterpretationLikely pathogenic (threshold 0.564)

DynaMut2

FieldValue
ΔΔG (kcal/mol)1.13 (Stabilising)
Job ID178092121347
Result URLhttps://biosig.lab.uq.edu.au/dynamut2/results_prediction/178092121347

Clinical Evidence

FieldValue
ClassificationUncertain significance
Review statuscriteria provided, single submitter
Last evaluated2023/08/30 00:00
InheritanceInheritance pattern not specified in ClinVar entry; WFS1 has both AD and AR presentations.
WFS1 variant landscapeH401Y is 1 of ~326 pathogenic-spectrum variants in WFS1 (out of 2,243 catalogued in ClinVar)

(no conditions catalogued)


Research Path Decision Tree

ΔΔG < 2  + binding site affected   →  CATEGORY 3 — docking experiments
ΔΔG 2–4                            →  CATEGORY 2 — pharmacological chaperones
ΔΔG > 4                            →  CATEGORY 1 — gene therapy
pLDDT < 50                         →  CATEGORY 5 — IDR, experimental only
Stable fold + functional site hit  →  CATEGORY 4 — site-specific docking

Final Schema Categorization

Category 3/4 — Most Druggable

<strong>Category 3/4 — Most Druggable</strong><br/><br/>|ΔΔG|=1.13 < 2 kcal/mol (fold intact) + AlphaMissense 0.747 confirms functional impact. Specific local contacts disrupted — priority for docking and pharmacological chaperone screening.

Why this card matters. Wolframin's fold survives this substitution (|ΔΔG|=1.13 kcal/mol). The pathogenic signal is real — AlphaMissense places it at 0.747. Protein still folds, but a specific local site is broken. Pharmacological chaperones and small-molecule binders are the rational therapeutic vector.


Files in this folder

  • AF-O76024-F1-model_v6.pdb — AlphaFold structure
  • H401Y_molstar_viewer.html — interactive 3D viewer (auto-highlights position 401 with ball-and-stick + neighbors within 5Å)
  • H401Y_variant_card.md — this card (source of truth)
  • H401Y_variant_card.html — styled printable card
  • H401Y_dynamut2_summary.html — clean offline DynaMut2 result card
  • dynamut2_result.json — structured result data
  • dynamut2_result_page.html — local snapshot of the Biosig result page (asset URLs absolutized)
  • H401Y_wildtype_interactions.pse / H401Y_mutant_interactions.pse — PyMOL sessions

Generated by wolfram-variant-card skill · RareResearch.AI Molecular Atlas Every assumption documented. Every score sourced.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the H401Y PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download H401Y PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.